Skip to content
Bills from the 2019–20 session

Senate Bill 100

Registration and regulation of pharmacy benefit managers, drug pricing transparency, granting rule-making authority, and providing a penalty. (FE)

Stopped in committee

It had a but no committee vote, so it never came up for a vote. To try again, a lawmaker would have to start a new bill.

  1. Introduced, passed

    Mar 15, 2019

  2. Committee, stopped here

    Stopped here. It had a hearing but no committee vote.

  3. Senate vote, not reached

  4. Assembly vote, not reached

  5. Governor, not reached

  6. Law, not reached

Latest entry in the official record, Apr 1, 2020: “Failed to pass pursuant to ⁠”

It sat with the Senate Committee on Health and Human Services.

Read the bill

Following saves it on this device. New actions show on your Following page. You can also get updates in a feed reader.

What it would have done

Summary by the , the Legislature's nonpartisan drafting office. It's their wording, not ours.

This bill generally allows the commissioner of insurance to regulate pharmacy benefit managers by requiring them to register. The bill also establishes certain price transparency requirements and requirements on contracts the pharmacy benefit manager enters into with pharmacies, pharmacists, or health benefit plan sponsors among other requirements.

Registration of pharmacy benefit managers The bill prohibits a person, except an insurer already regulated by the commissioner, from performing any activities of a pharmacy benefit manager in this state without first registering with the commissioner. Certain pharmacy benefit managers must be licensed by the Pharmacy Examining Board and registered as a pharmacy benefit manager. If the Pharmacy Examining Board revokes the pharmacy or distributor license for such a pharmacy benefit manager, the commissioner must revoke the pharmacy benefit manager's registration. An applicant for registration as a pharmacy benefit manager must file an appropriate application and pay any registration fee set by the commissioner. A registration is valid for one year. The commissioner may refuse to register a pharmacy benefit manager for which a previous registration was suspended or revoked.

Read the full summary

Under the bill, the commissioner, after a hearing, may suspend or revoke a registration of a pharmacy benefit manager if the registered pharmacy benefit manager, or an officer, director, or employee of a registered pharmacy benefit manager, does any of the actions specified in the bill. The commissioner may promulgate rules necessary to carry out the intent of pharmacy benefit manager registration. The bill also allows the commissioner to use his or her authority that is granted to regulate insurers to similarly regulate pharmacy benefit managers, including the authority to require reports, conduct examinations, and issue orders.

The commissioner is required to promulgate certain rules, including rules regarding formulary development, required disclosures, and a standardized medical exceptions approval process, among others.

The bill requires pharmacy benefit managers to provide a reasonably adequate and accessible network of pharmacies. Pharmacy benefit managers are not allowed to include mail-order pharmacies in their calculation of network adequacy. The bill requires pharmacy benefit managers to submit a network adequacy report to the commissioner. The bill also imposes on pharmacy benefit managers a current law requirement on health maintenance organizations, limited service health organizations, and preferred provider plans that provide coverage of pharmaceutical services when performed by one or more selected pharmacists to provide an annual period of at least 30 days during which any pharmacist may elect to participate in the organization or plan under its terms as a selected provider for at least one year.

Pharmacy benefit manager regulation The bill requires pharmacy benefit managers to refrain from certain actions in their interactions with pharmacists or pharmacies including charging a pharmacist or pharmacy a fee related to the adjudication of a claim, requiring pharmacist or pharmacy accreditation or certification requirements in addition to, more stringent than, or inconsistent with requirements of the pharmacy examining board, reimbursing a pharmacist or pharmacy less than the amount reimbursed to an affiliate of the pharmacy benefit manager for the same services, failing to make payments for services properly provided by a pharmacist or pharmacy before the termination of the pharmacist or pharmacy from the network, and restricting or limiting a pharmacy or pharmacist from disclosing information to a governmental official or law enforcement that is investigating a complaint or conducting a review.

The bill requires a pharmacy benefit manager to disclose to a health benefit plan sponsor any activity, policy, or practice that presents a conflict of interest and, if the pharmacy benefit manager makes a formulary substitution to a higher cost drug, the cost of the drug and any benefit that accrues to the pharmacy benefit manager related to the substitution. A pharmacy benefit manager is prohibited in the bill from retroactively denying a pharmacist's or pharmacy's claim unless the original claim was fraudulent, the payment of the original claim was incorrect because it had already been paid, or the pharmacy services were not rendered by the pharmacist or pharmacy. The bill requires every pharmacy benefit manager to submit annual transparency reports containing information specified in the bill to the commissioner and to certain committees of the legislature.

Current law requires pharmacy benefit managers to agree in their contracts to make certain disclosures regarding prescription drug reimbursement, including updating maximum allowable cost pricing information for prescribed drugs or devices at least every seven business days, reimbursing pharmacies or pharmacists subject to the updated maximum allowable cost pricing, and modifying information in the maximum allowable cost information in a timely fashion. Pharmacy benefit managers currently must also include in each contract with a pharmacy a process to appeal, investigate, and resolve pricing disputes in accordance with the specifics in current law. These current law requirements are unchanged by the bill.

Audits of pharmacists or pharmacies The bill sets requirements on a pharmacy benefit manager, insurer, defined network plan, such as a health maintenance organization, or a third-party payer that is conducting an audit of pharmacist or pharmacy records, including requiring at least two weeks' notice of an audit that is on the premises of a pharmacist or pharmacy, refraining from conducting the audit within the first seven days of the month unless the pharmacist or pharmacy consents, limiting the audit to claims submitted no more than two years before the date of the audit, establishing a written appeals process allowing for appeals of preliminary and final reports and mediation by either party, and allowing a pharmacist or pharmacy to use health care provider records to validate records and any prescription that complies with the pharmacy examining board requirements to validate claims. The bill requires an entity that has conducted an audit of a pharmacist or pharmacy to comply with certain timing requirements for delivery of the preliminary and final reports and for allowing a pharmacist or pharmacy to address any discrepancies and requires the entity to refrain from using extrapolation in calculating the recoupments or penalties from an audit among other requirements in the bill. If an audit identifies a clerical or record-keeping error, the pharmacy benefit manager or entity must prove that the pharmacist or pharmacy intended to commit fraud or that the error resulted in actual financial harm before requesting recoupment from the pharmacist or pharmacy based on the error. A pharmacy benefit manager or other entity conducting an audit may not pay an auditor based on a percentage of the amount recovered in an audit.

Allowing disclosures to consumers This bill prohibits a health insurance policy, referred to in the statutes as a disability insurance policy, or a governmental self-insured health plan from including in a contract for pharmacy services, or allowing a pharmacy benefit manager or another entity to include in a contract for pharmacy services, a provision that prohibits or penalizes a pharmacist's disclosure to an individual purchasing a prescribed drug or device of the cost of a prescribed drug or device, a less expensive therapeutically equivalent drug or device, or a less expensive method of purchasing the drug or device.

Cost sharing limitation, choice of provider, and drug substitution The bill sets a limitation on the amount of cost sharing that a person who is covered under a health insurance policy or self-insured governmental health plan must pay at the point of sale for a prescription drug as specified in the bill. A policy or plan or a pharmacy benefit manager may not require a person covered under the policy or plan to pay an increased amount of cost sharing for a newly prescribed drug or device if the policy, plan, or pharmacy benefit manager requested the substitution of the original drug and if the newly prescribed drug or device is therapeutically equivalent to the originally prescribed drug or device. The bill requires health insurance policies, self-insured governmental health plans, and pharmacy benefits managers to develop a procedure to ensure that a policy or plan does not deny coverage to an insured or plan participant during a plan year or subject the insured or plan participant to new exclusions, limitations, deductibles, copayments, or coinsurance if the prescribed drug or device was covered under the policy or plan for the insured or plan participant when the insured or plan participant either enrolled in coverage or renewed coverage and if the prescribing health care provider states that the prescribed drug or device is more suitable for the insured's or plan participant's condition than alternative drugs or devices that are covered under the policy or plan. An insurer, self-insured governmental health plan, or pharmacy benefit manager may not require or penalize a person who is covered under a health insurance policy or plan to use or for not using a specific retail, specific mail order pharmacy, or other specific pharmacy within the policy's or plan's provider network.

This proposal may contain a health insurance mandate requiring a social and financial impact report under s. 601.423, stats.

Who's behind it

17 senators are its ⁠. 9 are Republicans and 8 are Democrats.

74 more lawmakers ⁠.

See all 91 names

Authors (17)

Signed on in support (74)

What it would cost

State agencies filed a . Each opens as a PDF from the Legislature.

Versions and amendments

Every text the Legislature printed for this bill, including proposed changes. Each opens on the Legislature's site.

What happened

  1. Apr 1, 2020

    The session ended, and the bill died with it.

  2. Feb 19, 2020

    1 more representative signed on in support.

  3. Feb 18, 2020

    “Commissioner of Insurance report received pursuant to s.601.423(2), Wisconsin Statutes” (the official wording)

  4. Feb 14, 2020

    1 more representative signed on in support.

  5. Feb 12, 2020

    The committee held a public hearing.

  6. Jan 22, 2020

    A state agency sent in its estimate of the cost.

  7. May 8, 2019 to Sep 26, 2019

    9 more representatives and 4 senators signed on in support.

  8. Apr 3, 2019

    A state agency sent in its estimate of the cost.

  9. Apr 2, 2019

    “Commissioner of Insurance report received pursuant to s.601.423(2), Wisconsin Statutes” (the official wording)

  10. Apr 1, 2019

    A state agency sent in its estimate of the cost.

  11. Mar 29, 2019

    A state agency sent in its estimate of the cost.

  12. Mar 20, 2019 to Mar 27, 2019

    1 more representative and 1 senator signed on in support.

  13. Mar 15, 2019

    Sent to the Senate Committee on Health and Human Services.

  14. Mar 15, 2019

    Introduced in the Senate.

See the official record, word for word
  1. Mar 15, 2019 · Senate

    Introduced by Senators Erpenbach, Roth, Bernier, Darling, Feyen, Hansen, Johnson, Larson, Marklein, Olsen, Ringhand, Smith, L. Taylor, Tiffany, Wanggaard, Wirch and Cowles; cosponsored by Representatives Schraa, Kolste, Anderson, Born, Bowen, Brooks, Brostoff, Considine, Dittrich, Duchow, Edming, Emerson, Felzkowski, Fields, Goyke, Gundrum, Hebl, Hesselbein, Horlacher, Hutton, James, Kitchens, Knodl, Krug, Kuglitsch, Meyers, Murphy, Mursau, Novak, Ohnstad, Oldenburg, Petersen, Plumer, Quinn, Ramthun, Riemer, Rodriguez, Rohrkaste, Sargent, Shankland, Sinicki, Sortwell, Skowronski, Spiros, Spreitzer, Snyder, Stafsholt, Stubbs, Stuck, Subeck, Summerfield, Swearingen, Tauchen, C. Taylor, Thiesfeldt, Tittl, Tranel, VanderMeer, Vorpagel and Vruwink

  2. Mar 15, 2019 · Senate

    Read first time and referred to Committee on Health and Human Services

  3. Mar 20, 2019 · Senate

    Senator Bewley added as a coauthor

  4. Mar 27, 2019 · Senate

    Representative Tusler added as a cosponsor

  5. Mar 29, 2019 · Senate

    Fiscal estimate received

  6. Apr 1, 2019 · Senate

    Fiscal estimate received

  7. Apr 2, 2019 · Senate

    Commissioner of Insurance report received pursuant to s.601.423(2), Wisconsin Statutes

  8. Apr 3, 2019 · Senate

    Fiscal estimate received

  9. May 8, 2019 · Senate

    Representatives Gruszynski and Vining added as cosponsors

  10. May 9, 2019 · Senate

    Senator Miller added as a coauthor

  11. Jun 21, 2019 · Senate

    Representative Wittke added as a cosponsor

  12. Aug 20, 2019 · Senate

    Representatives Pronschinske and Kulp added as cosponsors

  13. Aug 23, 2019 · Senate

    Senator Carpenter added as a coauthor

  14. Aug 29, 2019 · Senate

    Senator Schachtner added as a coauthor

  15. Sep 4, 2019 · Senate

    Representatives Magnafici and Crowley added as cosponsors

  16. Sep 6, 2019 · Senate

    Representative Billings added as a cosponsor

  17. Sep 12, 2019 · Senate

    Senator Risser added as a coauthor

  18. Sep 26, 2019 · Senate

    Representative Milroy added as a cosponsor

  19. Jan 22, 2020 · Senate

    Fiscal estimate received

  20. Feb 11, 2020 · Senate

    Senate Substitute Amendment 1 offered by Senator Roth

  21. Feb 12, 2020 · Senate

    Public hearing held

  22. Feb 14, 2020 · Senate

    Representative McGuire added as a cosponsor

  23. Feb 18, 2020 · Senate

    Commissioner of Insurance report received pursuant to s.601.423(2), Wisconsin Statutes

  24. Feb 19, 2020 · Senate

    Representative Hintz added as a cosponsor

  25. Apr 1, 2020 · Senate

    Failed to pass pursuant to Senate Joint Resolution 1

Terms on this page

Committee

A small group of lawmakers that looks at a bill first. Most bills never leave committee.

More in the glossary

Public hearing

A meeting where anyone can speak to a committee about a bill, or send written comments.

More in the glossary

Senate Joint Resolution 1

The session's calendar. Any bill not passed by its last voting day dies.

Official term: Failed to pass pursuant to SJR 1. More in the glossary

Legislative Reference Bureau

The Legislature's nonpartisan office that drafts bills and writes the summary at the top of each one.

Official term: LRB analysis. More in the glossary

Author

A lawmaker who formally puts a bill forward. The text itself is drafted by the Legislative Reference Bureau.

Official term: Author, coauthor. More in the glossary

Signed on in support

Lawmakers who back a bill without being one of its authors, often from the other chamber.

Official term: Cosponsor. More in the glossary

Cost estimate

A state agency's estimate of what a bill would cost or save.

Official term: Fiscal estimate. More in the glossary

From the Wisconsin Legislature's official record, checked Sep 15, 2026. See the source

Committee

A small group of lawmakers that looks at a bill first. Most bills never leave committee.

Public hearing

A meeting where anyone can speak to a committee about a bill, or send written comments.

Senate Joint Resolution 1

The session's calendar. Any bill not passed by its last voting day dies.

Official term: Failed to pass pursuant to SJR 1

Legislative Reference Bureau

The Legislature's nonpartisan office that drafts bills and writes the summary at the top of each one.

Official term: LRB analysis

Author

A lawmaker who formally puts a bill forward. The text itself is drafted by the Legislative Reference Bureau.

Official term: Author, coauthor

Signed on in support

Lawmakers who back a bill without being one of its authors, often from the other chamber.

Official term: Cosponsor

Cost estimate

A state agency's estimate of what a bill would cost or save.

Official term: Fiscal estimate